Patents by Inventor Mark Chandy

Mark Chandy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of the adverse cardiovascular effects of cannabinoids
    Publication number: 20240307342
    Abstract: Treatment of the adverse cardiovascular effects of cannabinoids in a subject with genistein or a genistein derivative.
    Type: Application
    Filed: April 26, 2023
    Publication date: September 19, 2024
    Applicant: GreenStone Biosciences, Inc.
    Inventors: Joseph C Wu, Jade Chao, Mark Chandy, Paul Pang
  • METHODS FOR DETERMINING RISK OF DEVELOPING INSULIN RESISTANCE
    Publication number: 20220273591
    Abstract: Compositions, methods, and kits are provided for determining whether a subject is at risk of developing insulin resistance. In particular, phosphorylated Akt, reactive oxygen species (ROS), SIRT1, eNOS, CDH13, IRS1 and NO production have been identified as biomarkers associated with insulin resistance and type 2 diabetes. The diagnostic methods comprise measuring the level of at least one biomarker in induced pluripotent stem cells derived from somatic cells of the subject, which have been differentiated into endothelial cells (IPSC-ECs).
    Type: Application
    Filed: July 24, 2020
    Publication date: September 1, 2022
    Inventors: Joseph C. Wu, Edward Lau, Mark Chandy